Zacks Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.54M | Buy |
135,845
+7,757
| +6% | +$145K | 0.02% | 294 |
|
|
2025
Q1 | $2.3M | Buy |
128,088
+42,665
| +50% | +$768K | 0.02% | 304 |
|
|
2024
Q4 | $1.44M | Buy |
+85,423
| New | +$1.44M | 0.01% | 374 |
|
|
2024
Q3 | – | Sell |
-39,016
| Closed | -$321K | – | 756 |
|
|
2024
Q2 | $321K | Sell |
39,016
-3,412
| -8% | -$28K | ﹤0.01% | 499 |
|
|
2024
Q1 | $628K | Buy |
42,428
+12,193
| +40% | +$180K | 0.01% | 448 |
|
|
2023
Q4 | $438K | Buy |
+30,235
| New | +$438K | 0.01% | 482 |
|